Loading…
Loading…
Last amendment: > on 2025-02-28.
Base rate computed from analyst-asserted responds_to: edges in the reverse direction (target-country → issuer-country) for prior issuer-actions on the same target. Modal type + lag percentiles only — not a model output. Treat as a historical anchor for sizing counter-response scenarios, not a forecast in itself.
The UEL Working Mechanism is a MOFCOM-led body (comprising the National Development and Reform Commission, Ministry of Industry and Information Technology, and other agencies) established under the 19 September 2020 "Provisions on the Unreliable Entity List." UEL designation authorises one or more of the following measures against the listed entity: (a) prohibition from engaging in import/export activities relating to China; (b) prohibition on making new investments in China; (c) barring grant or renewal of work permits and stay/residence permits for relevant personnel; (d) fines proportionate to the severity of the violation.
PVH Group (PVH Corp; NYSE: PVH): MOFCOM launched a formal investigation in September 2024 under the UEL framework, citing PVH's decision to avoid sourcing Xinjiang cotton across its Calvin Klein and Tommy Hilfiger supply chains. The February 2025 listing concluded that investigation. The designation is notable because PVH's Xinjiang-sourcing decision was made under threat of US Uyghur Forced Labor Prevention Act (UFLPA) enforcement rather than as a purely commercial choice — making the UEL listing a direct instrument of Chinese extra-territorial counter-pressure against US supply-chain legislation. PVH derives roughly 6–8 % of revenues from Greater China.
Illumina Inc. (NASDAQ: ILMN): Cited for restricting Chinese customers' access to gene-sequencing instruments and reagents, characterised by MOFCOM as discriminatory measures that damage Chinese enterprises' legitimate interests. The 28 February 2025 follow-up announcement converted the listing into a concrete export bar on gene-sequencing equipment, effectively mirroring the US BIS approach of restricting technology flows — but in the reverse direction. Illumina had been in an extended dispute with Chinese authorities over the iCAS regulatory framework, and the UEL designation coincided with broader PRC effort to develop domestic substitutes (e.g., MGI Tech, a BGI spin-off, which is the principal domestic alternative to Illumina).
Timing: The announcement was issued the same day (4 February 2025) as China's first IEEPA-tariff retaliation package, making both actions part of a coordinated same-day counter-punch to Trump Executive Order 14195 (1 February 2025). This is the second UEL action in 2025 following Announcement [2025] No. 1 (10 US defense entities, 2 January 2025 — responding to Taiwan arms sales). The combination of commercial-brand UEL listing, biotech export bar, and concurrent mineral/energy tariffs indicates a broader, multi-instrument retaliation toolkit.